StockIQ.techEurofins Scientific SE (ERF.PA) Stock Analysis
Free AI-powered analysis and research for Eurofins Scientific SE stock
Sector: Healthcare
ERF.PA snapshot
Data as of 4 Nov 2026 close. Updated daily.
Eurofins Scientific SE scores 76/100 on StockIQ's model, which reads as strongly positive signals overall. The price is above its 200-day average and at 98% of its 52-week range, up 47.1% over the past year. Latest reported figures show a profit margin of 7.2%, return on equity of 11.3% and revenue growth of +2.5%.
What is driving the score
- Strong Uptrend: +12
- MACD Bullish: +8
- High P/E (30.5): -10
- Weak Liquidity (1.13 Current Ratio): -5
- Strong Long-term Uptrend: +8
- Strong Momentum (+47.1% over 1 year): +8
- Near 52-Week High (98%): +5
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full ERF.PA report
Eurofins Scientific SE (ERF.PA) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze ERF.PA Now →📰 Latest Update
Missed Eurofins Scientific's Run? What Holders Had To Believe
Tue, October 20, 2026 at 1:12 PM UTC 3 min read
Eurofins Scientific (ERF.PA) recently reported strong quarterly results, exceeding market expectations and showcasing robust growth in its testing services. This performance highlights the company's resilience and adaptability in a competitive market, making it an attractive option for investors seeking stability and growth potential. As the demand for scientific testing continues to rise, Eurofins' positive outlook may encourage both current holders and potential investors to reassess their positions.